Search This Blog

Thursday, October 24, 2019

ResMed EPS beats by $0.06, beats on revenue

ResMed (NYSE:RMD): Q1 Non-GAAP EPS of $0.93 beats by $0.06; GAAP EPS of $0.83 beats by $0.10.
Revenue of $681.1M (+15.8% Y/Y) beats by $20.23M.
Press Release
https://seekingalpha.com/news/3509301-resmed-eps-beats-0_06-beats-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)